120
Participants
Start Date
March 21, 2025
Primary Completion Date
February 1, 2027
Study Completion Date
July 1, 2027
Tideglusib
Tideglusib 1g po daily
Placebo
Matching placebo 1g po daily
NOT_YET_RECRUITING
Foothills Medical Centre, Calgary
NOT_YET_RECRUITING
St. Paul's Hospital, Vancouver
RECRUITING
Victoria Cardiac Arrhythmia Trials Inc., Victoria
NOT_YET_RECRUITING
Health Sciences Centre, St. John's
NOT_YET_RECRUITING
Queen Elizabeth II Health Sciences Centre, Halifax
RECRUITING
Hamilton General Hospital, Hamilton
NOT_YET_RECRUITING
Kingston General Hospital, Kingston
RECRUITING
London Health Sciences Centre, London
NOT_YET_RECRUITING
Newmarket Electrophysiologist Research Group 'NERG', Newmarket
NOT_YET_RECRUITING
University of Ottawa Heart Institute, Ottawa
RECRUITING
Heart Health Institute Research Inc, Scarborough Village
NOT_YET_RECRUITING
Sunnybrook Health Sciences Centre, Toronto
NOT_YET_RECRUITING
St. Michael's Hospital, Toronto
RECRUITING
Montreal Heart Institute, Montreal
NOT_YET_RECRUITING
McGill University Health Centre, Montreal
NOT_YET_RECRUITING
Hopital du Sacré-Coeur de Montréal, Montreal
RECRUITING
University Institute of Cardiology and Pneumology of Quebec, Québec
Collaborators (2)
Population Health Research Institute
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
AMO Pharma
UNKNOWN
Hearts in Rhythm Organization (HiRO)
UNKNOWN
Canadian SADS
UNKNOWN
Hamilton Health Sciences Corporation
OTHER